Tissue Repair & Skin · Research Blend

KLOW (Four-Peptide Blend)

A four-peptide research blend — GHK-Cu, TB-500, BPC-157, and KPV — combining collagen, cell-migration, cytoprotective, and anti-inflammatory research pathways in one vial.

KLOW is a four-peptide research blend built around GHK-Cu (50mg) with TB-500, BPC-157, and KPV at 10mg each — 80mg of total peptide content, the composition used consistently across the research-supply market. Each component carries its own substantial preclinical literature, and the blend exists so laboratories can study how their mechanisms interact in a single model system.

KLOW can be thought of as a more inclusive version of the “Wolverine” stack: it contains the complete BPC-157 + TB-500 pairing (covered on our BB research page) and extends it with two additional, mechanistically distinct peptides — GHK-Cu, the copper-binding tripeptide with one of the largest bodies of collagen and skin-remodeling research, and KPV, a small anti-inflammatory tripeptide derived from the hormone α-MSH. The result spans four research axes: extracellular-matrix signaling, cell migration, cytoprotective repair signaling, and inflammation control. All supporting evidence is preclinical — cell and animal studies — and no human trials of the blend exist.

Research areas

Collagen & ECM Signaling

GHK-Cu — the largest share of the blend — is studied for stimulating collagen synthesis and modulating extracellular-matrix remodeling genes.

Cell Migration & Angiogenesis

TB-500's actin-sequestering activity and BPC-157's VEGFR2-pathway signaling are both investigated in vessel-formation and cell-motility models.

Cytoprotective Repair Signaling

BPC-157's rodent-model literature spans tendon, gut, muscle, and vascular repair — the "Wolverine" half of the blend.

Inflammation & Immune Signaling

KPV, the C-terminal tripeptide of α-MSH, is studied for anti-inflammatory activity, including PepT1-mediated uptake in intestinal-inflammation models.

View KLOW blend products

Recent research findings

2024Component research continued across all four peptides; multi-peptide blend designs became increasingly common in tissue-repair study protocols.
2023Reviews consolidated GHK-Cu's gene-modulation and antioxidant data alongside continuing BPC-157 and Tβ4 repair-model work.
2008–2021Foundational literature for each component — collagen stimulation (GHK-Cu), actin regulation (Tβ4), cytoprotection (BPC-157), and anti-inflammatory signaling (KPV) — established the mechanisms the blend is designed to co-study.

Published Research & Citations

The research summarized above is drawn from published, peer-reviewed studies. Explore the 6 sources below — links open the abstract or, where marked, the full free article on the U.S. National Library of Medicine (PubMed / PMC).

Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 2018. Free full text Open-access review mapping GHK-Cu effects on wound healing, gene expression, and tissue regeneration.
Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu. FEBS Letters, 1988. Foundational study showing GHK-Cu stimulates collagen synthesis in fibroblast cultures.
Xing Y, et al. Progress on the Function and Application of Thymosin β4. Frontiers in Endocrinology, 2021. Free full text Open-access review of Tβ4's roles in actin regulation, angiogenesis, and tissue regeneration.
Seiwerth S, et al. Stable gastric pentadecapeptide BPC 157 and wound healing. Frontiers in Pharmacology, 2021. Free full text Open-access review of BPC 157 across rodent wound-healing models.
Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 2008. Key study of KPV's anti-inflammatory activity via PepT1 transport in intestinal-inflammation models.
Brzoska T, et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo. Endocrine Reviews, 2008. Review of α-MSH-derived tripeptides (including KPV) and their anti-inflammatory signaling.